Search results for "block"

showing 10 items of 1177 documents

Is atrial sensing of ventricular far-field signals important in single-lead VDD pacing?

1998

UNLABELLED In single-lead VDD pacing the atrial sensitivity frequently is programmed to sensitive values. Atrial sensing of ventricular far-field signals should be reduced by differential atrial sensing. The aim of the study was to evaluate the effectiveness of this approach. METHODS The study included 10 patients with a single-lead VDD pacemaker (Thera 8948, Lead 5032). The atrial sensitivity was set to its most sensitive value of 0.18 mV and the telemetered intraatrial EGM was continuously recorded. After atrial tracked ventricular pacing, VVI pacing was performed with pacing rates from 100 to 160 beats/min in steps of 10 beats/min and up to 165 beats/min. The peak-to-peak amplitudes of P…

Malemedicine.medical_specialtyPacemaker ArtificialHeart blockAtrial sensingInternal medicinemedicineHumansTelemetrySinus rhythmcardiovascular diseasesAgedbusiness.industryRate dependentCardiac Pacing ArtificialGeneral MedicineVentricular pacingmedicine.diseaseElectrodes ImplantedHeart BlockSingle leadcardiovascular systemVdd pacingCardiologyFemaleCardiology and Cardiovascular MedicinebusinessPacing and clinical electrophysiology : PACE
researchProduct

Permanent Pacemaker Lead Insertion Connected to an External Pacemaker Generator for Temporary Pacing After Transcatheter Aortic Valve Implantation.

2019

Abstract Background Outcomes after transcatheter aortic valve implantation (TAVI) have been demonstrated to be at least equivalent in the short term compared to surgical valve implantation (SAVI). However, Conduction abnormalities are more common after TAVI than SAVI and the need for permanent pacemaker implantation is more common after TAVI with the currently commercially available self-expanding valves than after SAVI. Temporary pacemaker implantation may be associated with inability to ambulate, lead migration or perforation and infection. Depending on the monitoring system, some arrhythmias may not be detected. We examined the feasibility and safety of permanent pacemaker lead implantat…

Malemedicine.medical_specialtyPacemaker ArtificialPerforation (oil well)Context (language use)030204 cardiovascular system & hematologySingle CenterPericardial effusionRisk AssessmentTranscatheter Aortic Valve Replacement03 medical and health sciences0302 clinical medicineElectric Power SuppliesRisk FactorsmedicineHumans030212 general & internal medicineLead (electronics)AgedRetrospective StudiesAged 80 and overbusiness.industryCardiac Pacing ArtificialAtrial fibrillationArrhythmias CardiacGeneral MedicineEquipment Designmedicine.diseaseSurgeryTreatment OutcomeFeasibility StudiesFemalePatient SafetyPermanent pacemakerCardiology and Cardiovascular MedicinebusinessAtrioventricular blockCardiovascular revascularization medicine : including molecular interventions
researchProduct

Paroxysmal atrial fibrillation and high degree AV block: use of single-lead VDDR pacing with mode switching.

1998

Dual chamber rate responsive pacing incorporating a mode switching option is increasingly used in patients with chronic paroxysmal atrial fibrillation and high degree AV block. Single-lead VDDR pacemakers have rarely used for this indication. The purpose of this study was to determine their reliability of atrial sensing during atrial fibrillation, the percentage of atrial synchronous ventricular pacing, and the behavior of the sinus rate outside the phases of atrial fibrillation. We studied ten patients with a single-lead VDDR pacemaker implanted for this indication. Follow-up visits were performed at predischarge and after 1, 3, 6, 12, 18, and 24 months. During the mean follow-up period of…

Malemedicine.medical_specialtyPacemaker ArtificialTime FactorsParoxysmal atrial fibrillationVentricular stimulationInternal medicineAtrial FibrillationMedicineHumansSinus rhythmIn patientcardiovascular diseasesbusiness.industryP waveCardiac Pacing ArtificialAtrial fibrillationGeneral MedicineMiddle Agedmedicine.diseaseHeart BlockSingle leadAnesthesiacardiovascular systemCardiologyMode switchingFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesPacing and clinical electrophysiology : PACE
researchProduct

Voltage-Dependent Effects of Barnidipine in Rat Vascular Smooth Muscle

2003

The effects of the dihydropyridine nifedipine and its more lipophilic congener, barnidipine, were investigated in smooth muscle preparations from the rat in resting and depolarizing conditions. Both drugs relaxed precontracted aortic rings more potently in depolarizing conditions, barnidipine being more potent than nifedipine. Currents through Ca 2+ channels in rat vascular smooth muscle cells (A7r5) and in isolated rat cardiomyocytes were reduced more potently by both drugs at a holding potential of-40 mV than at -80 mV. However, barnidipine and nifedipine were more effective in reducing the current in A7r5 cells than in cardiomyocytes. The IC 50 obtained in aortic rings and in A7r5 cells …

Malemedicine.medical_specialtyPatch-Clamp TechniquesVascular smooth muscleBarnidipineNifedipinechemistry.chemical_elementPharmacologyCalciumMuscle Smooth VascularRats Sprague-DawleyNifedipineInternal medicinemedicineAnimalsMyocyteCells CulturedPharmacologyChemistryDihydropyridineDepolarizationCalcium Channel BlockersRatsEndocrinologyMechanism of actioncardiovascular systemFemalemedicine.symptomCardiology and Cardiovascular Medicinemedicine.drugJournal of Cardiovascular Pharmacology
researchProduct

Glucagon-like peptide-2 relaxes mouse stomach through vasoactive intestinal peptide release.

2009

Glucagon-like peptide-2 (GLP-2) influences different aspects of the gastrointestinal function, including epithelial growth, digestion, absorption, motility, and blood flow. Intraluminal pressure from isolated mouse stomach was recorded to investigate whether GLP-2 affects gastric tone and to analyze its mechanism of action. Regional differences between diverse parts of the stomach were also examined using circular muscular strips from fundus and antrum. In the whole stomach, GLP-2 (0.3–100 nM) produced concentration-dependent relaxation with a maximum that was about 75% of relaxation to 1 μM isoproterenol (IC50 = 2.5 nM). This effect was virtually abolished by desensitization of GLP-2 rece…

Malemedicine.medical_specialtyPhysiologyVasoactive intestinal peptideGastric motilityMotilityTetrodotoxinIn Vitro TechniquesPeptide hormoneBiologySettore BIO/09 - FisiologiaMiceenteric nervous systemPhysiology (medical)Internal medicineGlucagon-Like Peptide 2Pyloric AntrummedicineAnimalsChymotrypsingastric motilityGastric FundusEnzyme InhibitorsSympathomimeticsHepatologyStomachdigestive oral and skin physiologyIsoproterenolGastroenterologygastrointestinal hormoneGlucagon-like peptide-2Mice Inbred C57BLVIPNG-Nitroarginine Methyl EsterEndocrinologymedicine.anatomical_structureGastric EmptyingGastrointestinal hormoneGastrointestinal functionhormones hormone substitutes and hormone antagonistsSodium Channel BlockersVasoactive Intestinal Peptide
researchProduct

Efficacy of the long-acting nitro vasodilator pentaerithrityl tetranitrate in patients with chronic stable angina pectoris receiving anti-anginal bac…

2013

Background The organic nitrate pentaerithrityl tetranitrate (PETN) has been shown to have ancillary properties that prevent the development of tolerance and endothelial dysfunction. This randomized, double-blind, placebo-controlled, multicentre study (‘CLEOPATRA’ study) was designed to investigate the anti-ischaemic efficacy of PETN 80 mg b.i.d. (morning and mid-day) over placebo in patients with chronic stable angina pectoris. Methods and results A total of 655 patients were evaluated in the intention-to-treat population, randomized to PETN (80 mg b.i.d., n = 328) or placebo ( n = 327) and completed the study. Patients underwent treadmill exercise tests at randomization, after 6 and 12 wee…

Malemedicine.medical_specialtyRandomizationmedicine.drug_classVasodilator AgentsPopulationAdrenergic beta-AntagonistsPlacebo-controlled studyPlaceboAdrenergic beta-AntagonistsMedication AdherenceDouble-Blind MethodmedicineClinical endpointHumansPentaerythritol TetranitrateAngina StableEndothelial dysfunctioneducationBeta blockereducation.field_of_studyExercise Tolerancebusiness.industryMiddle Agedmedicine.diseaseSurgeryTreatment OutcomeAnesthesiaDelayed-Action PreparationsChronic DiseaseExercise TestFemaleCardiology and Cardiovascular MedicinebusinessEuropean heart journal
researchProduct

The effect of methacholine on noradrenaline release from the rabbit heart perfused with indometacin

1974

The experiments were undertaken in order to study the effect of inhibition of prostaglandin synthesis on the muscarinic inhibition of noradrenaline release evoked by sympathetic nerve stimulation. The right sympathetic nerves of the perfused rabbit heart were stimulated electrically. The noradrenaline output was enhanced after perfusion of the hearts with indometacin 3×10−5 M indicating blockade of the prostaglandin-mediated negative feedback control. Both in the presence and in the absence of indometacin methacholine 4×10−5 M decreased the noradrenaline output by a similar percentage. It is concluded that the muscarinic inhibition of noradrenaline release does not require the functional in…

Malemedicine.medical_specialtySympathetic Nervous SystemTime FactorsHeart VentriclesIndomethacinSympathetic nerveStimulationIn Vitro TechniquesFeedbackNorepinephrineIndometacinHeart RateInternal medicineMuscarinic acetylcholine receptormedicineAnimalsMethacholine CompoundsHeart AtriaPharmacologyChemistryMyocardiumRabbit heartHeartGeneral MedicineElectric StimulationStimulation ChemicalBlockadePerfusionEndocrinologyDepression ChemicalProstaglandinsFemaleMethacholineRabbitsPerfusionmedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Effects of clinical and laboratory variables at admission and of in-hospital treatment with cardiovascular drugs on short term prognosis of ischemic …

2011

Abstract Introduction No information exists, to our knowledge, about the possible role of cardiovascular drug administration in the acute phase of ischemic stroke and possible effects on stroke outcome. The aim of our study was to evaluate the relationship between in-hospital treatment with cardiovascular drugs in patients with acute ischemic stroke and some outcome indicators. Methods and Results 1096 subjects enrolled in the GIFA study, who had a main discharge diagnosis of ischemic stroke represent the final sample. Drugs considered for the analysis were the following: ACE-inhibitors (ACEI), angiotensin II receptor blockers (ARBs), statins, calcium-channel-blockers (CCBs), antiplatelet (…

Malemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismHypercholesterolemiaMedicine (miscellaneous)Angiotensin II Receptor BlockersCharlson indexAngiotensin-Converting Enzyme InhibitorsComorbidityBrain IschemiaInternal medicineActivities of Daily LivingmedicineHumansIn patientcardiovascular diseasesStrokeGeriatric AssessmentAgedRetrospective StudiesNutrition and Dieteticsbusiness.industryCardiovascular AgentsHeparinmedicine.diseaseCalcium Channel BlockersPrognosisStrokeHospital treatmentItalyIschemic strokeHypertensionPhysical therapyFunctional statusFemaleCardiology and Cardiovascular MedicinebusinessCognition DisordersPlatelet Aggregation Inhibitorsmedicine.drugNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

Metabolic and Cardiovascular Effects of Switching Thiazides to Amlodipine in Hypertensive Patients With and Without Type 2 Diabetes (the Diuretics an…

2020

Background: Different studies have indicated that thiazide diuretics can increase the risk of developing type 2 diabetes (T2D). Therefore, in this study, we investigated whether switching from hydrochlorothiazide (HCTZ) to amlodipine resulted in ameliorating different cardiovascular and metabolic measures in hypertensive patients with or without T2D. Methods: This study [Diuretics and Diabetes Control (DiaDiC)] was a 6-week, single-blind, single-center randomized controlled trial. The first 20 normal glucose-tolerant, 20 prediabetic, and 20 T2D consecutive patients were randomized to continue the previous antihypertensive treatment with HCTZ (12.5-25 mg/day) or to switch from HCTZ to amlodi…

Malemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismSodium Chloride Symporter InhibitorsdiureticBlood PressureType 2 diabetesSettore MED/13 - EndocrinologiaInternal medicineInternal MedicineMedicineHumansSingle-Blind MethodAmlodipineSettore MED/49 - Scienze Tecniche Dietetiche ApplicateThiazideAntihypertensive AgentsAgedtreatmentbusiness.industryDrug Substitutioncardiovascularfood and beveragesMiddle Agedmedicine.diseaseCalcium Channel BlockersDiabetes controlHydrochlorothiazideTreatment OutcomeDiabetes Mellitus Type 2ItalyHypertensionCardiologyFemaletype 2 diabetesAmlodipinethiazidebusinessEnergy MetabolismmetabolismBiomarkersmedicine.drugMetabolic syndrome and related disorders
researchProduct

Comparison between local and regional anesthesia in arteriovenous fistula creation.

2011

Purpose Assessment of the effectiveness of Brachial Plexus Block (BPB) via axillary approach compared to regional anesthesia for arteriovenous fistula surgery in patients affected by end-stage renal disease. Methods We compared forty patients randomly divided into two groups. Group A underwent BPB procedure with 15 mL ropivacaine 1% and 10 mL of saline (0.9% NaCl) via axillary approach. Group B received local anesthesia with lidocaine 2%. The forearm blood vessels were assessed by Doppler ultrasonography before and after the intervention. Results BPB performed on Group A was associated with a considerable venous dilation and a significant decrease (48.7%, P<.05) in pulsatility index (PI)…

Malemedicine.medical_specialtyTime Factorslocal and regional anesthesiaFistulaArteriovenous fistulaSettore MED/41 - AnestesiologiaVeinsArteriovenous Shunt SurgicalForearmRenal DialysisOcclusionmedicineHumansLocal anesthesiaBrachial PlexusRopivacaineAnesthetics Localarteriovenous fistulaBrachial plexus blockarteriovenous fistula; local and regional anesthesiaAgedRopivacainebusiness.industryLidocaineNerve BlockUltrasonography DopplerMiddle Agedmedicine.diseaseThrombosisAmidesSurgeryVasodilationSettore MED/18 - Chirurgia GeneraleForearmmedicine.anatomical_structureTreatment OutcomeItalyNephrologyAnesthesiaRadial ArteryKidney Failure ChronicSurgeryFemalebusinessmedicine.drugAnesthesia LocalThe journal of vascular access
researchProduct